The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumours
暂无分享,去创建一个
V. R. McCready | J. Griffiths | M. Leach | S. Eccles | T. A. Smith | J. Titley | M. Ormerod | M. O. Leach | S. Baluch | A. Tombs | J. Griffiths | V. McCready
[1] J. Stack,et al. 31P MRS as an early prognostic indicator of patient response to chemotherapy , 1992, Magnetic resonance in medicine.
[2] V. R. McCready,et al. The effect of intra‐tumour heterogeneity on the distribution of phosphorus‐containing metabolites within human breast tumours: An In Vitro study using 31P NMR spectroscopy , 1991, NMR in biomedicine.
[3] M. Leach,et al. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. , 1991, British Journal of Cancer.
[4] M. Chowdhury,et al. Purification and Characterization of Rat Uterine Glycerylphosphorylcholine Diesterase and Its Tissue-Specific Induction by 17β-Estradiol , 1991 .
[5] H. Magdelenat,et al. Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation. , 1991, British Journal of Cancer.
[6] R. Coombes,et al. Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS. , 1991, British Journal of Cancer.
[7] J. Hemmer. Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors. , 1990, Cytometry.
[8] D. Collins,et al. IN-VIVO 31P MAGNETIC RESONANCE SPECTROSCOPY FOR MONITORING TREATMENT RESPONSE IN BREAST CANCER , 1989, The Lancet.
[9] T. Ng,et al. Therapeutic response of breast carcinoma monitored by 31P MRS in situ , 1989, Magnetic resonance in medicine.
[10] J. Griffiths,et al. Potential artefacts from overlying tissues in 31p NMR spectra of subcutaneously implanted rat tumours , 1989, NMR in biomedicine.
[11] R. Coombes,et al. 31P-nuclear magnetic resonance spectroscopy studies of the response of rat mammary tumors to endocrine therapy. , 1988, Cancer research.
[12] W. Fiers,et al. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice. , 1987, Cancer research.
[13] T. Brown,et al. Observation of myo-inositol 1,2-(cyclic) phosphate in a Morris hepatoma by 31P NMR. , 1987, The Journal of biological chemistry.
[14] D. Vance,et al. Reduction of phosphatidylcholine turnover in a Nb 2 lymphoma cell line after prolactin treatment. A novel mechanism for control of phosphatidylcholine levels in cells. , 1986, The Journal of biological chemistry.
[15] Enrico,et al. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice. , 1986, Cancer research.
[16] S. E. Petersen,et al. Flow cytometry of human colorectal tumors: nuclear isolation by detergent technique. , 1985, Cytometry.
[17] B. Chance,et al. 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. , 1985, The New England journal of medicine.
[18] C. Warden,et al. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. , 1985, The Journal of biological chemistry.
[19] D. Vance,et al. Diethylstilbestrol treatment increases the amount of choline kinase in rooster liver. , 1982, Biochimica et biophysica acta.
[20] W. McGuire,et al. Improved sensitivity in the measurement of estrogen receptor in human breast cancer. , 1973, The Journal of clinical endocrinology and metabolism.